Both in Pharmaceuticals
Citius Pharmaceuticals vs Neuphoria Therapeutics
Over the past year CTXR returned −59.5% and NEUP returned −29.4%; their daily moves had a correlation of 0.12.
CTXR −59.5% NEUP −29.4%Growth of $1, one year, split-adjusted
| Metric | CTXR | NEUP |
|---|---|---|
| Price | $0.5510 | $2.98 |
| Market cap | $15.1M | $16.1M |
| Today | −3.87% | −0.33% |
| 1 month | +14.6% | −13.6% |
| 6 months | −17.3% | −44.6% |
| Year to date | −29.1% | −23.2% |
| 1 year | −63.8% | −32.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | 67.1% | — |
| Net margin | −593.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.1× | — |
| Net cash | $10.6M | — |
| Dividend yield | — | — |
| Volatility (60d) | 96.0% | 27.6% |
| Short % of float | 21.9% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).